Tools

A pivotal trial of Gilead Sciences Inc’s drug idelalisib has been stopped early after independent monitors determined that the drug… »   

A high dose of Pfizer Inc’s drug, tofacitinib, proved as effective as the widely used treatment Enbrel in treating adults… »   

The FDA has approved riociguat (Adempas) for patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH).

The… »   

Swiss drugmaker Novartis said on Saturday its drug omalizumab was almost doubly effective in improving quality of life for patients… »   

The U.S. Food and Drug Administration said on Friday it has approved Baxter International Inc’s nutritional supplement Clinolipid, moving quickly… »   

A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

“We are the… »   

GlaxoSmithKline and Theravance’s new inhaled lung drug Relvar has been approved in Japan, a day after winning a positive recommendation… »   

Sanofi SA has reached a $40 million settlement of a U.S. lawsuit accusing the French drugmaker of misleading investors about… »   

Biologists at the University of California, San Diego have developed a revolutionary new method for identifying and characterizing antibiotics, an… »   

Repurchasing L’Oreal’s 9 percent stake in Sanofi might make sense for the French drugmaker if the $12 billion holding is… »